Strategic partnerships Strong ties with Fujifilm and ongoing collaboration with NYU Langone Health indicate a track record of co-development and clinical validation. Sales opportunities exist in leveraging渠道 partnerships for integrated endoscopy solutions and expanding US adoption through these relationships.

Global expansion Established presence in Israel with a US subsidiary suggests readiness for regional scaling. Target expansions into additional markets with accredited distributors and clinical centers to accelerate adoption of G-EYE technology and balloon-assisted endoscopy.

Regulatory readiness ISO 13485 certification and FDA clearance CE marking demonstrate strong compliance foundations. Use these credentials to approach hospitals and procurement teams prioritizing compliant, easily integrable endoscopy enhancements.

Innovative offerings G-EYE and NaviAid balloon technologies aim to enhance detection and efficiency without heavy investments. Position as cost-effective upgrades for existing endoscopy stacks, appealing to centers seeking performance gains with manageable ROI.

Clinical validation Clinical collaborations and FDA-cleared platforms indicate real-world efficacy. Highlight evidence and case studies in sales pitches to gastroenterology departments focused on improving polyp detection rates and procedure throughput.